Theoretical and clinical practice of metabolic associated fatty liver disease based on the theory of “six stagnation diseases”
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 10
Abstract
Metabolic associated fatty liver disease （MAFLD） has become the most common liver disease in the world， including simple hepatic steatosis， steatohepatitis， liver fibrosis/cirrhosis， and liver cancer， and it is often associated with metabolic syndrome. MAFLD has complex pathological manifestations， and there are still no new drugs on the market in China. In the past， traditional Chinese medicine often treated this disease from the perspective of food， phlegm-dampness， damp-heat， or liver depression and spleen deficiency， but a detailed analysis showed that the pathological process of the disease was consistent with the theory of “six stagnation diseases” in traditional Chinese medicine. This article briefly introduces the origin of the pathogenic theory of “six stagnation diseases”， the pathological features of the “six stagnation diseases” leading to fatty liver disease， the key points of syndrome differentiation and treatment， and clinical practice， so as to promote clinical treatment through an in-depth understanding of the traditional Chinese medicine pathogenesis of MAFLD.
Authors and Affiliations
Guangdong TONG, Yuxin SUN
Keywords
Related Articles
- EP ID EP751078
- DOI 10.12449/JCH241004
- Views 17
- Downloads 0
Expert consensus on Traditional Chinese Medicine diagnosis and treatment of jaundice（2023）
Jaundice is one of the common clinical symptoms，which is characterized by eyes stained yellow especially. The classification and prescription of jaundice are improved continuously. This consensus describes the history o...
The genetic association between nonalcoholic fatty liver disease and type 2 diabetes mellitus in different body mass index categories： A bidirectional Mendelian randomization study
[Objective] To investigate the genetic association between nonalcoholic fatty liver disease （NAFLD） and type 2 diabetes mellitus （T2DM） using bidirectional two-sample Mendelian randomization （MR）， as well as the c...
Research advances in the pathogenesis of metabolic associated fatty liver disease
Metabolic associated fatty liver disease （MAFLD） is currently the most common liver disease around the world. MAFLD may easily progress to the adverse outcomes such as hepatitis， liver fibrosis， and liver cirrhosis，...
An excerpt of American College of Gastroenterology guidelines： Management of acute pancreatitis （2024）
The American College Gastroenterology （ACG） recently released the 2024 edition of Guidelines for the management of acute pancreatitis. The guidelines first discuss the diagnosis， etiology， severity， and early manage...
Efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with advanced hepatocellular carcinoma
[Objective] To investigate the efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with unresectable or advanced hepatocellular carcinoma （HCC）. [Methods...